Cross-linked high amylose starch resistant to amylase as a matrix for the slow release of biologically active compounds
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 4, 2001
Grant Date -
N/A
app pub date -
Feb 24, 1998
filing date -
Feb 24, 1998
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention is concerned with a solid slow release oral pharmaceutical dosage unit resistant to amylase which comprises a solid dosage unit made up of an admixture of a therapeutic dosage of an orally effective pharmaceutical product, an optional polysaccharide or polyol, and cross-linked high amylose starch, wherein the cross-linking of the high amylose starch has been carried out with a covalent or non-covalent cross-linking agent with from about 0.1 g to about 30 g of cross-linking agent per 100 g of high amylose starch.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully